What are peptides — and why is everyone suddenly talking about them?

What are peptides anyway?

Peptides are short chains of amino acids. Amino acids are the building blocks your body uses to make proteins — hair, muscles, hormones, enzymes. When the chain is short (rule of thumb: fewer than ~50 amino acids), we call it a peptide. When it's longer, we call it a protein. The boundary is fuzzy.

The most important example you probably know: insulin. Insulin is a peptide. It was discovered in 1921 in Toronto and has been used as a medicine since 1922 — the first patient ever treated with it was a 14-year-old boy named Leonard Thompson. Without peptides, modern diabetes treatment would not exist.

What has happened in recent decades: we can now make peptides industrially — amino acid by amino acid — instead of extracting them from animals (as original insulin came from pig pancreases). The technology that made this possible (solid-phase peptide synthesis, SPPS) was invented by Bruce Merrifield in 1963 and won him the Nobel Prize in 1984. That is the foundation for everything on the market today.

How long have we been working with them?

Over 100 years. A rough timeline:

1. 1921Insulin is discovered in Toronto — proof that we can replace the body's own messengers with a medicine.
2. 1953Vincent du Vigneaud chemically synthesises oxytocin and vasopressin in the lab. Nobel Prize 1955.
3. 1963Bruce Merrifield invents solid-phase peptide synthesis — peptides become industrially producible.
4. 1970sRoger Guillemin and Andrew Schally identify the hypothalamic hormones (GHRH, TRH, somatostatin). Nobel Prize 1977.
5. 1990s–2000sFirst synthetic GLP-1 analogs: exenatide (Byetta) approved 2005, liraglutide 2010, semaglutide 2017.
6. 2017–todaySemaglutide (Ozempic, Wegovy) reaches the broad public. Tirzepatide (Mounjaro) follows in 2022. Peptides suddenly become a lifestyle topic.

In other words: the science behind peptides is old, well established and has earned multiple Nobel Prizes. What is new is the media attention, not the substance.

Why the sudden trend?

Three things are happening at once:

1. The semaglutide success story. Approved in 2017 as a diabetes medication, it turned out to be so effective for weight loss that it received a second approval in 2021 as Wegovy — in a clinical trial (STEP-1) participants lost an average of about 15 % of their body weight. That is a magnitude previously reached only by bariatric surgery. Suddenly "peptide" was on the evening news.

2. The industrialisation of synthesis. Companies like Bachem and Polypeptide Group have grown from specialist suppliers into industrial giants over the past 20 years. Peptides are now made in metric tonnes. That makes them commercially interesting — and also widely available on the grey market.

3. A bro-science wave. Parallel to legitimate therapies, a subculture has formed in bodybuilding, longevity and bio-hacking forums that experiments with peptides — BPC-157, TB-500, GHK-Cu, GHRP-6 and many others. These substances are often not approved as medicines anywhere. What looks safe in a YouTube video or a Reddit thread is often scientifically restricted to animal studies.

This is what makes the field confusing: some peptides have dozens of randomised human trials and are available in pharmacies. Others have one rat study from 1995 and are marketed in the same language. This platform tries to make that difference visible.

How do peptides differ from a classic drug?

Most medicines you know — aspirin, paracetamol, antibiotics, blood-pressure pills — are "small molecules". These are chemically synthesised compounds that are stable in a tablet and can be absorbed through the digestive tract.

Peptides are different:

• Larger
  Often 10 to 100 times the size of a classic drug molecule.
• More fragile
  Most do not survive the stomach. They get broken down by digestion — which is why peptide medicines are mostly injected.
• More specific
  Because they resemble the body's own messengers, they often bind very precisely to a single receptor — fewer off-target side effects.
• More expensive
  Synthesis and purity control are demanding. A month of Wegovy without insurance costs several hundred dollars in the US.

There are exceptions — semaglutide also exists as a tablet (Rybelsus), albeit with substantially lower bioavailability than the injection. Such solutions are the exception, not the rule.

Are peptides dangerous?

The honest answer: "peptides" is too broad a category for a single answer. That is like asking "are medicines dangerous?"

More useful is the distinction by approval status, because that determines how well we actually know the risk:

Important: "peptide" is not a magic label for "safe". The class contains substances with every possible risk profile — from insulin (life-saving, exquisitely documented) to substances whose safety in humans has never been tested.

Three categories in which peptides appear

So you know what you are looking at:

How to read this platform

Every peptide entry uses the same structure:

• Profile at the topWhat it is, how it acts, how long it stays in the body, what it has been studied for.
• EvidenceWhat studies have observed — EVERY claim carries an evidence tier (human-RCT > human-trial > animal > in-vitro > anecdotal). The colour shows it at a glance.
• Legal statusCountry by country — approved, not approved, restricted, banned. With source and date.
• Risks & adverse eventsWhat studies have documented — not what we speculate.
• Anecdotal reportsWhat forums claim — deliberately separated from established evidence, with a clear caveat.

If you see pale grey on an observation, that means: anecdotal or cell culture. Bright green: randomised human trial. That colour scale is the fastest way to read a peptide.

What this platform does NOT do

Just to be clear — this platform:

• ·does not give dose or usage recommendations.
• ·does not name sources to buy from.
• ·makes no therapeutic promises.
• ·is not a substitute for medical advice.

We contextualise, compare, explain — and leave every decision to you and your doctor. If you are considering a peptide therapy, the consultation in a clinic is the right next step, not a forum post.

Where to go next

If specific peptides interest you, here are a few good starting points: